Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

A 64-year-old woman underwent a coronary flow reserve evaluation using intracoronary-administered papaverine into the left anterior descending artery. Her baseline electrocardiogram (ECG) was normal, but toward the end of papaverine administration, the QTU intervals were excessively prolonged and torsade de pointes occurred, leading to ventricular fibrillation. Ten months previously, the patient's ECG showed mildly prolonged QTc (480 ms1/2), which normalized after the cessation of bepridil. This case report suggests that a history of drug-induced QT prolongation can be a risk factor for papaverine-induced fatal ventricular arrhythmia. © 2014 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Goto, M., Sato, M., Kitazawa, H., Takahashi, M., Fuse, K., Saito, A., … Aizawa, Y. (2014). Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation. Internal Medicine, 53(15), 1629–1631. https://doi.org/10.2169/internalmedicine.53.1828

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free